| Title |
Year |
Author |
Number |
| INDOLIZINE DERIVATIVES, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF INHIBITION OF ACTIVITY OF TESTOSTERONE-5α-REDUCTASE |
1992 |
- Satosi Okada
- Kozo Savada
- Akio Kuroda
- Sinija Vatanabe
- Khirokazu Tanaka
|
RU2120942C1 |
| 1,2,3,4-TETRAHYDROPYRAZOLO-[5,1-C]-(1,2,4)-TRIAZINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, PHARMACEUTICAL COMPOSITION INHIBITING PRODUCING AN INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR, METHOD OF PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PATIENTS WITH DISEASES MEDIATED BY INTERLEUKIN AND TUMOR NECROSIS FACTOR |
1994 |
- Esio Kavai
- Khitosi Jamazaki
- Khirokazu Tanaka
- Teruo Oku
|
RU2124517C1 |
| GUANIDINE DERIVATIVES, METHOD OF PREPARATION THEREOF, AND METHOD FOR INHIBITING Na/H EXCHANGE IN CELLS |
1994 |
- Atsusi Kuno
- Josikazu Inou
- Khisasi Takasugi
- Khiroaki Mizuno
- Kumi Jamasaki
|
RU2141946C1 |
| CEPHEM COMPOUND OR ITS PHARMACEUTICALLY ACCEPTABLE SALT |
1992 |
- Khideaki Jamanaka[Jp]
- Esiki Esida[Jp]
- Dziro Goto[Jp]
- Takesi Tarasava[Jp]
- Sinia Okuda[Jp]
- Kazuo Sakane[Jp]
|
RU2024530C1 |
| METHOD OF SYNTHESIS OF PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1990 |
- Matsuo Masaaki[Jp]
- Tsudzi Kiesi[Jp]
- Konisi Nobukie[Jp]
- Nakamura Katsuja[Jp]
|
RU2021990C1 |
| HETEROCYCLIC COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT |
1994 |
- Teruo Oku
- Khirosi Kajakiri
- Sigeki Satokh
- Josito Abe
- Juki Savada
- Takajjuki Inoju
- Khirokazu Tanaka
|
RU2135478C1 |
| POLYPEPTIDE COMPOUNDS, METHOD OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHOD OF PROPHYLAXIS AND/OR THERAPEUTIC TREATMENT |
1994 |
- Khidenori Okhki
- Masaki Tomisima
- Akira Jamada
- Khisasi Takasugi
|
RU2164230C2 |
| CARPAPENEM DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF |
1992 |
- Tosijuki Nisi[Jp]
- Khiroko Koda[Jp]
- Kazujuki Sugita[Jp]
- Iokhkhej Isida[Jp]
- Makoto Takemura[Jp]
- Takesi Khajano[Jp]
|
RU2091381C1 |
| PYRAZOLE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS |
1993 |
- Masaaki Matsuo
- Kijosi Tsudzi
- Takasi Ogino
- Nobukijo Konisi
|
RU2128172C1 |
| PEPTIDE DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, METHOD OF SYNTHESIS OF PEPTIDE DERIVATIVES AND PHARMACEUTICAL COMPOSITION |
1991 |
- Kejdzi Khemmi[Jp]
- Masakhiro Neja[Jp]
- Naoki Fukami[Jp]
- Masasi Khasimoto[Jp]
- Khirokazu Tanaka[Jp]
- Natsuko Kajakiri[Jp]
|
RU2092491C1 |
wherein R1 is heteryl(lower)alkyl, (C1-C12) alkyl and optionally substituted phenyl (lower) alkyl; R2 is H, phenyl (lower)alkoxycarbonyl or optionally substituted phenylsulphonyl; R3 is carboxy (lower) alkyl, etherified carboxylower alkyl, carboxyphenyl or etherified carboxyphenyl and pharmaceutically acceptable salts thereof. Said salts are prepared by reacting compound of formula II: 
with compound of formula XIV: 
or salt thereof. Present invention describes pharmaceutical composition which has antagonistic activity against thromboxane A2(TXA2) and inhibits TXA2 synthase based on compound I. EFFECT: improved properties of the pharmaceutical composition. 9 cl